Australian Clinical Labs Limited ACL.AX Stock
Australian Clinical Labs Limited Price Chart
Australian Clinical Labs Limited ACL.AX Financial and Trading Overview
| Australian Clinical Labs Limited stock price | 2.46 AUD |
| Previous Close | 3.26 AUD |
| Open | 3.27 AUD |
| Bid | 3.25 AUD x N/A |
| Ask | 3.26 AUD x N/A |
| Day's Range | 3.22 - 3.3 AUD |
| 52 Week Range | 2.84 - 5.6 AUD |
| Volume | 821.22K AUD |
| Avg. Volume | 562.69K AUD |
| Market Cap | 657.98M AUD |
| Beta (5Y Monthly) | 1.380053 |
| PE Ratio (TTM) | 9.055555 |
| EPS (TTM) | 0.08 AUD |
| Forward Dividend & Yield | 0.48 (14.71%) |
| Ex-Dividend Date | March 27, 2023 |
| 1y Target Est | 4 AUD |
ACL.AX Valuation Measures
| Enterprise Value | 960.76M AUD |
| Trailing P/E | 9.055555 |
| Forward P/E | 14.173913 |
| PEG Ratio (5 yr expected) | -0.45 |
| Price/Sales (ttm) | 0.8044587 |
| Price/Book (mrq) | 3.7342496 |
| Enterprise Value/Revenue | 1.175 |
| Enterprise Value/EBITDA | 7.351 |
Trading Information
Australian Clinical Labs Limited Stock Price History
| Beta (5Y Monthly) | 1.380053 |
| 52-Week Change | -24.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.6 AUD |
| 52 Week Low | 2.84 AUD |
| 50-Day Moving Average | 3.47 AUD |
| 200-Day Moving Average | 3.4 AUD |
ACL.AX Share Statistics
| Avg. Volume (3 month) | 562.69K AUD |
| Avg. Daily Volume (10-Days) | 352.25K AUD |
| Shares Outstanding | 201.83M |
| Float | 122.48M |
| Short Ratio | N/A |
| % Held by Insiders | 7.16% |
| % Held by Institutions | 70.00% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.48 |
| Trailing Annual Dividend Yield | 14.72% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 1.4492999 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 8.97% |
| Operating Margin (ttm) | 14.22% |
| Gross Margin | 37.16% |
| EBITDA Margin | 15.97% |
Management Effectiveness
| Return on Assets (ttm) | 11.48% |
| Return on Equity (ttm) | 38.44% |
Income Statement
| Revenue (ttm) | 817.92M AUD |
| Revenue Per Share (ttm) | 4.08 AUD |
| Quarterly Revenue Growth (yoy) | -33.00000000000000000000000000000000% |
| Gross Profit (ttm) | 450.08M AUD |
| EBITDA | 130.69M AUD |
| Net Income Avi to Common (ttm) | 73.45M AUD |
| Diluted EPS (ttm) | 0.36 |
| Quarterly Earnings Growth (yoy) | -80.50% |
Balance Sheet
| Total Cash (mrq) | 16.13M AUD |
| Total Cash Per Share (mrq) | 0.08 AUD |
| Total Debt (mrq) | 323.08M AUD |
| Total Debt/Equity (mrq) | 184.47 AUD |
| Current Ratio (mrq) | 0.633 |
| Book Value Per Share (mrq) | 0.873 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 164.98M AUD |
| Levered Free Cash Flow (ttm) | 154.15M AUD |
Profile of Australian Clinical Labs Limited
| Country | Australia |
| State | VIC |
| City | Clayton |
| Address | 1868-1892 Dandenong Road |
| ZIP | 3168 |
| Phone | 61 3 9538 6777 |
| Website | https://www.clinicallabs.com.au |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 5400 |
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Q&A For Australian Clinical Labs Limited Stock
What is a current ACL.AX stock price?
Australian Clinical Labs Limited ACL.AX stock price today per share is 2.46 AUD.
How to purchase Australian Clinical Labs Limited stock?
You can buy ACL.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Australian Clinical Labs Limited?
The stock symbol or ticker of Australian Clinical Labs Limited is ACL.AX.
Which industry does the Australian Clinical Labs Limited company belong to?
The Australian Clinical Labs Limited industry is Diagnostics & Research.
How many shares does Australian Clinical Labs Limited have in circulation?
The max supply of Australian Clinical Labs Limited shares is 201.83M.
What is Australian Clinical Labs Limited Price to Earnings Ratio (PE Ratio)?
Australian Clinical Labs Limited PE Ratio is 30.75000200 now.
What was Australian Clinical Labs Limited earnings per share over the trailing 12 months (TTM)?
Australian Clinical Labs Limited EPS is 0.08 AUD over the trailing 12 months.
Which sector does the Australian Clinical Labs Limited company belong to?
The Australian Clinical Labs Limited sector is Healthcare.
Australian Clinical Labs Limited ACL.AX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| S&P/ASX SMALL ORDINARIES AXSO | 3055.7 AUD 2022.44 USD |
-0.94
|
— — | 3042.1 AUD 2013.44 USD | 3084.6 AUD 2041.56 USD | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| S&P/ASX 300 AXKO | 7711.3 AUD 5103.78 USD |
-0.4
|
— — | 7688.2 AUD 5088.49 USD | 7743.1 AUD 5124.83 USD | — - | — — |
- {{ link.label }} {{link}}